Cordis and BrosMed launch ceremony for the localization strategy at CIIE China
Release time:
2023-11-09
The Sixth China International Import Expo (CIIE) kicked off in Shanghai on November 5, 2023, As one of the world’s largest import-themed exhibitions, the CIIE attract a diverse range of exhibitors and enterprises to participate from across the world for global trade and economic cooperation.
The Sixth China International Import Expo (CIIE) kicked off in Shanghai on November 5, 2023, As one of the world’s largest import-themed exhibitions, the CIIE attract a diverse range of exhibitors and enterprises to participate from across the world for global trade and economic cooperation.
Through the CIIE, Cordis and BrosMed Medical seize this opportunity to launch ceremony for the localization strategy aim to deepen “Chinese Wisdom, Global Co-creation,” and promote the innovation ecosystem in the China market to empower grassroots healthcare.
This marks Cordis’ first step toward achieving local manufacturing in China. In April of this year, Cordis had already partnered with BrosMed Medical Co., Ltd. to jointly implement Cordis’ first Marketing Authorization Holder (MAH) project in China. They signed agreements for commissioned research and development and production of the SABER 0.014” PTA balloon dilatation catheter.
Mr. Cai Yulun, General Manager of Cordis China, said, ” Today is just the starting point. In the future, we look forward to continuing to work with BrosMed Medical to combine the global wisdom with local innovation to create a larger innovation ecosystem to support the development of healthcare.”
Mr. Benny Lee, CEO of BrosMed Medical, said, “As a representative of outstanding medical device manufacturers in China, BrosMed Medical has been cooperating with Cordis for over six years. We will work with Cordis’ global team to exert our strength on product research and development, providing more innovative products for global patients and creating a successful example of close cooperation between international brands and Chinese manufacturers.”
Cordis and BrosMed Medical will continue to uphold the mutual original commitment to innovation, maintain a patient-centered philosophy, persistently cultivate in the field of vascular intervention, and convey care to vascular disease patients worldwide.
Contact Us to Become BrosMed Partner!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27
Meet BrosMed at Leipzig Interventional Course (LINC 2024)
We’re excited to announce that BrosMed team will attend LINC 2024 from May 28th to 31th in Leipzig, Germany. Leipzig Interventional Course is an exciting event that bringing the global vascular community together. As a company committed to improving clinic outcomes through innovative medical devices, we look forward to connecting with industry experts, physicians, and partners at this premier conference.
2024-05-14
Webinar Invitation | Creating A Successful Endovascular Practice. Apr. 29
Date: April 29, 2024 Time: 17:00-19:10 (Korean Standard Time) 16:00-18:10 (Beijing Time) 16:00-18:10 (Malaysia Time) 11:00-13:10 (Moscow Standard Time) 11:00-13:10 (Egypt Standard Time)
2024-04-24